SCHEMBL6973188

SCHEMBL6973188

O=C(O)[C@@H]1CCCCN1c1nc2ccc(Cl)cc2s1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.56
RAB9A P51151 6/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
CNR2 P34972 2/20 0.49
MAPT P10636 2/20 0.49
PPARD Q03181 3/20 0.47
PPARG P37231 2/20 0.47
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
HTT P42858 1/20 0.46
PPARA Q07869 1/20 0.44
POLB P06746 1/20 0.44
HCRTR1 O43613 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27494737 0.84 TSHR (0.51) NPC1RAB9ASMN1; SMN2CNR2MAPT
SCHEMBL6967758 0.83 RAB9A (0.51) NPC1RAB9ASMN1; SMN2MAPTCYP2C9
SCHEMBL1199326 0.79 NPC1 (0.52) NPC1RAB9ASMN1; SMN2MAPTCYP2C9
SCHEMBL11985482 0.79 NPC1 (0.52) NPC1RAB9ASMN1; SMN2MAPTCYP2C9
SCHEMBL2565667 0.78 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CNR2MAPT
SCHEMBL2563234 0.78 NPC1 (0.50) NPC1RAB9ASMN1; SMN2CNR2MAPT
SCHEMBL6968220 0.78 DRD2 (0.47)
SCHEMBL6976138 0.78 DRD2 (0.47)
SCHEMBL9033129 0.76 NPC1 (0.55) NPC1RAB9ASMN1; SMN2CNR2MAPT
SCHEMBL9033137 0.76 NPC1 (0.55) NPC1RAB9ASMN1; SMN2CNR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1611499-A Heterocyclic compounds as inhibitors of rotamase enzymes PFIZER (US) 2005-05-04 CN disclosed
CN-1174978-C Heterocyclic compounds useful as rotamase inhibitors 2004-11-10 CN disclosed
CN-1511837-A Intermediate for heterocyclic compound in preparing rotamase inhibitor 2004-07-14 CN disclosed
US-6562964-B1 Inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases or other disorders PFIZER INC 2003-05-13 US disclosed
EP-1100797-B1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LTD (GB) 2003-02-26 EP disclosed
US-6372736-B1 ENZYME INHIBITORS PFIZER INC 2002-04-16 US disclosed
CN-1310718-A Heterocyclic compounds useful as rotamase inhibitors PFIZER LTD (US) 2001-08-29 CN disclosed
EP-1100797-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES Pfizer Limited (GB) 2001-05-23 EP disclosed
WO-2000005232-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ROTAMASE ENZYMES PFIZER LIMITED (GB) 2000-02-03 WO disclosed